Evaluation of Liver Damage in Patients With Anorexia Nervosa by Blood Biomarker Analysis
The main goal of the BIocoLlection in Anorexia Nervosa-liver damage evaluation BILAN study the blood biomarkers associated with liver cytolysis.
- EligibilityCriteria: Inclusion Criteria :  Patient over 15 years old Diagnosis of Restricted Eating Disorders including Anorexia Nervosa according to the Diagnostic and Statistical Manual of Mental Disorders (DSM-5) Admission to Nantes University Hospital.  Exclusion Criteria :  Chronic active viral hepatitis Hemochromatosis Other genetic, autoimmune. Treatment with a drug known to induce fatty liver disease (amiodarone, carbamazepine, tamoxifen, valproate, clozapine, anti-retrovirals) unless the dose has been stable for ≥ 3 months Excessive alcohol consumption (≥ 30 grams per day in men, ≥ 20 grams per day in women) Pregnant, parturient or breast-feeding women, persons deprived of liberty, adults under legal protection or unable to express their consent, persons not affiliated or not beneficiaries of a social security scheme, persons under guardianship or curators - HealthyVolunteers: No - Gender: All - MinimumAge: 15 Years - MaximumAge: 99 Years - StdAgeList: Child, Adult, Older Adult - StudyPopulation: Consecutive inclusion of patients hospitalized in the endocrinology department for anorexia nervosa with malnutrition criteria. - SamplingMethod: Probability Sample